NYC To Celebrate Opening of AIDS Vaccine Laboratory on November 12
IAVI will open a state-of-the-art AIDS vaccine lab at the landmark Brooklyn Army Terminal during a ribbon-cutting ceremony on November 12.
IAVI Commends UK Government’s Commitment to Ending AIDS
The UK government announced today it would contribute £220 million over five years to support product development research for new tools to stop the spread of HIV.
IAVI Releases 2008 AIDS Vaccine Blueprint
In its biennial AIDS Vaccine Blueprint: A Challenge to the Field, a Roadmap for Progress, IAVI puts forth a series of concrete recommendations to help guide future AIDS vaccine research and development, including a series of interim milestones against which progress in the field can be charted.
South Africa Plays Role in AIDS Vaccine Discovery Efforts
IAVI awards South Africa’s Elevation Biotech with an innovation grant to help develop novel vaccine immunogens that elicit broadly neutralizing antibodies against HIV.
New AIDS Vaccine Research Center Established
IAVI and The Scripps Research Institute have launched the world’s first research center dedicated exclusively to solving the most pressing challenge facing AIDS vaccine researchers today—how to elicit broadly neutralizing antibodies against HIV.
Strengthening the response to HIV and AIDS: Helping make the MDGs a reality
A new IAVI policy brief, endorsed by 43 partner organizations, examines the critical role that the response to HIV/AIDS plays in advancing the Millennium Development Goals.
|